A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients’ survival in gastric cancer

被引：0
|
作者：
Weili Wang
Ping Liao
Yijing He
机构：
[1] Xiangya Hospital,Department of Clinical Pharmacology, Institute of Clinical Pharmacology
[2] Central South University,Department of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis
[3] Xiangya Hospital,undefined
来源：
Cancer Immunology, Immunotherapy | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1379 / 1381
页数：2
相关论文
共 50 条
  • [1] A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients' survival in gastric cancer
    Wang, Weili
    Liao, Ping
    He, Yijing
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (10) : 1379 - 1381
  • [2] PD-L1 methylation regulates PD-L1 expression and is associated with melanoma survival
    Micevic, Goran
    Thakral, Durga
    McGeary, Meaghan
    Bosenberg, Marcus W.
    PIGMENT CELL & MELANOMA RESEARCH, 2019, 32 (03) : 435 - 440
  • [3] A polymorphism in the promoter region of PD-L1 serves as a binding-site for SP1 and is associated with PD-L1 overexpression and increased occurrence of gastric cancer
    Li-Hua Tao
    Xin-Ru Zhou
    Fu-Chao Li
    Qi Chen
    Fan-Yi Meng
    Yong Mao
    Rui Li
    Dong Hua
    Hong-Jian Zhang
    Wei-Peng Wang
    Wei-Chang Chen
    Cancer Immunology, Immunotherapy, 2017, 66 : 309 - 318
  • [4] A polymorphism in the promoter region of PD-L1 serves as a binding-site for SP1 and is associated with PD-L1 overexpression and increased occurrence of gastric cancer
    Tao, Li-Hua
    Zhou, Xin-Ru
    Li, Fu-Chao
    Chen, Qi
    Meng, Fan-Yi
    Mao, Yong
    Li, Rui
    Hua, Dong
    Zhang, Hong-Jian
    Wang, Wei-Peng
    Chen, Wei-Chang
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (03) : 309 - 318
  • [5] Expression of PD-L1 in gastric cancer
    Polushkina, T.
    Sotnikova, T.
    Kalinin, D.
    Danilova, N.
    VIRCHOWS ARCHIV, 2024, 485 : S499 - S499
  • [6] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
  • [7] PD-L1 Protein Expression and PD-L1 Gene Amplification in Breast Cancer
    Voronel, Olga
    Dalvi, Siddhartha
    Kallakury, Bhaskar Vs
    Sheehan, Christine E.
    Boguniewicz, Ann B.
    Ross, Jeffrey S.
    LABORATORY INVESTIGATION, 2016, 96 : 77A - 77A
  • [8] PD-L1 Protein Expression and PD-L1 Gene Amplification in Breast Cancer
    Voronel, Olga
    Dalvi, Siddhartha
    Kallakury, Bhaskar V. S.
    Sheehan, Christine E.
    Boguniewicz, Ann B.
    Ross, Jeffrey S.
    MODERN PATHOLOGY, 2016, 29 : 77A - 77A
  • [9] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [10] Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer
    Imai, Yushi
    Chiba, Tetsuhiro
    Kondo, Takayuki
    Kanzaki, Hiroaki
    Kanayama, Kengo
    Ao, Junjie
    Kojima, Ryuta
    Kusakabe, Yuko
    Nakamura, Masato
    Saito, Tomoko
    Nakagawa, Ryo
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Tawada, Akinobu
    Matsumura, Tomoaki
    Nakagawa, Tomoo
    Kato, Jun
    Kotani, Ai
    Matsubara, Hisahiro
    Kato, Naoya
    ONCOLOGY LETTERS, 2020, 20 (03) : 2161 - 2168
12345